BenevolentAI Revenue and Competitors
Estimated Revenue & Valuation
- BenevolentAI's estimated annual revenue is currently $87.9M per year.
- BenevolentAI received $115.0M in venture funding in April 2018.
- BenevolentAI's estimated revenue per employee is $217,000
- BenevolentAI's total funding is $292M.
- BenevolentAI's current valuation is $1B.
Employee Data
- BenevolentAI has 405 Employees.
- BenevolentAI grew their employee count by 25% last year.
BenevolentAI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Founder | Reveal Email/Phone |
3 | Group CEO | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | VP Product Management | Reveal Email/Phone |
6 | VP Business Development | Reveal Email/Phone |
7 | Director Drug Discovery - Nonclinical Safety | Reveal Email/Phone |
8 | Deployment Operations Manager | Reveal Email/Phone |
9 | Group Finance Manager | Reveal Email/Phone |
10 | Finance Manager | Reveal Email/Phone |
BenevolentAI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A | N/A |
What Is BenevolentAI?
BenevolentAI is the global leader in the development and application of artificial intelligence (AI) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world's 8,000 untreated diseases. Our team of technologists, AI researchers, and scientists builds and applies AI to the entire drug discovery and development process. The technology unlocks what is not known by creating new ideas based on established facts to provide a different understanding of disease, which leads to inventive steps and real insights that drive the development of new medicines and treatments. The goal To get the right treatments to the right patients at the right time *Reach out to us* Email: hello@benevolent.ai Careers: Careers@benevolent.ai Twitter: @benevolent_ai Website: benevolent.ai
keywords:Biotechnology, Healthcare, Artificial Intelligence, Technology
$292M
Total Funding
405
Number of Employees
$87.9M
Revenue (est)
25%
Employee Growth %
$1B
Valuation
N/A
Accelerator
BenevolentAI News
LONDON, April 25, 2022 /PRNewswire/ -- BenevolentAI (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company,...
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company headquartered in London, with a research facility in Cambridge (UK)...
LONDON, April 21, 2022 /PRNewswire/ -- BenevolentAI, a leading clinical-stage artificial intelligence (AI) enabled drug discovery company, today...
Alec G., Tech Times 17 April 2020, 12:04 pm A.I. might have found the potential cure for COVID-19, and it is already being tested in clinical trials. (Photo : www.pexels.com) Read More: Apple Online Store Down Amidst Preorders of New iPhone SE The Tell of The Tale BenevolentAI, a London star ...
BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has announced a new collaboration, with ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $146.8M | 405 | 24% | N/A |
#2 | $136.7M | 405 | 18% | N/A |
#3 | $73.4M | 405 | 10% | N/A |
#4 | $62.8M | 405 | 25% | N/A |
#5 | $76.1M | 406 | -4% | N/A |
BenevolentAI Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-04-19 | $115.0M | Undisclosed | Article |